end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableAndAccruedLiabilitiesCurrent,AccountsPayableFairValueDisclosure,AccruedLiabilitiesCurrent,AccruedProfessionalFeesCurrent,AdditionalPaidInCapital,AdjustmentsToAdditionalPaidInCapitalStockSplit,AllocatedShareBasedCompensationExpense,Assets,AssetsCurrent,Cash,CashAndCashEquivalentsAtCarryingValue,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect,CommonStockConvertibleConversionPriceIncrease,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValue,DebtInstrumentFaceAmount,DebtInstrumentIncreaseAccruedInterest,DebtInstrumentIncreaseDecreaseOtherNet,DebtWeightedAverageInterestRate,DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense,DeferredCompensationLiabilityCurrent,DeferredCosts,EarningsPerShareBasicAndDiluted,EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions,EquityMethodInvestmentOwnershipPercentage,GeneralAndAdministrativeExpense,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,IncreaseDecreaseInAccountsPayableAndAccruedLiabilities,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,IncrementalCommonSharesAttributableToCallOptionsAndWarrants,InterestExpense,InterestExpenseDebt,InterestPaidNet,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,LiabilitiesNoncurrent,LongTermDebt,LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths,LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree,LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo,LongTermNotesPayable,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,NetIncomeLossAttributableToParentDiluted,NotesAndLoansPayableCurrent,NotesPayable,NotesPayableCurrent,NotesPayableRelatedPartiesCurrentAndNoncurrent,NotesPayableRelatedPartiesNoncurrent,OperatingExpenses,OperatingIncomeLoss,OtherAccountsPayableAndAccruedLiabilities,OtherGeneralAndAdministrativeExpense,OtherLongTermNotesPayable,OtherNoncashExpense,OtherNonoperatingIncomeExpense,OtherPrepaidExpenseCurrent,OtherResearchAndDevelopmentExpense,PaymentsOfFinancingCosts,PaymentsOfStockIssuanceCosts,PreferredStockParOrStatedValuePerShare,PreferredStockSharesAuthorized,PrepaidExpenseAndOtherAssetsCurrent,PrepaidInsurance,ProceedsFromDebtNetOfIssuanceCosts,ProceedsFromIssuanceInitialPublicOffering,ProceedsFromIssuanceOfCommonStock,ProceedsFromIssuanceOfDebt,ProceedsFromNotesPayable,ProceedsFromRelatedPartyDebt,ProfitLoss,RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty,RepaymentsOfDebt,RepaymentsOfNotesPayable,RepaymentsOfRelatedPartyDebt,ResearchAndDevelopmentExpense,RestrictedStockValueSharesIssuedNetOfTaxWithholdings,RetainedEarningsAccumulatedDeficit,SaleLeasebackTransactionGrossProceedsInvestingActivities,SaleOfStockConsiderationReceivedOnTransaction,SaleOfStockPricePerShare,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice,ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions,SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent,SharesIssued,SharesIssuedPricePerShare,StockholdersEquity,StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans,StockIssuedDuringPeriodSharesNewIssues,StockIssuedDuringPeriodSharesStockOptionsExercised,StockIssuedDuringPeriodValueIssuedForServices,StockIssuedDuringPeriodValueNewIssues,StockIssuedDuringPeriodValueOther,StockIssuedDuringPeriodValueShareBasedCompensationGross,UnearnedPremiums,WarrantExercisePriceIncrease,WeightedAverageNumberDilutedSharesOutstandingAdjustment,WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2020-12-31,2021-03-31,10-K,"Virpax Pharmaceuticals,Â Inc.",VRPX,CIK0001708331,USD,3115924.0,,270000.0,253462.0,6431715.0,,,465406.0,73069.0,54796.0,54796.0,54796.0,,,1e-05,100000000.0,3145153.0,3145153.0,31.0,,,,,,1031923.0,392337.0,,,,,,,,,,,,4681504.0,465406.0,3659914.0,1021590.0,,,,,1021590.0,,,,,543990.0,1565580.0,543990.0,1000000.0,1000000.0,,,15422.0,,21590.0,,,534.0,,,,1e-05,10000000.0,18273.0,8257.0,,,,,,,,,,,,,,-10647844.0,,,,,,,,,,,20225.0,269868.0,5.66,486101.0,9.89,9.89,9.89,,,,,-4216098.0,,,,,,,,2874.0,12.5,,
2021-03-31,2021-05-17,10-Q,"Virpax Pharmaceuticals,Â Inc.",VRPX,CIK0001708331,USD,2589520.0,,263431.0,153859.0,22584788.0,,,13219342.0,13219342.0,,12264285.0,12264285.0,12209489.0,12.5,1e-05,100000000.0,4945153.0,4945153.0,49.0,,,,,369884.0,1105060.0,,-0.6,142185.0,0.06,1273572.0,-2379271.0,-164766.0,936784.0,90000.0,30699.0,30699.0,34707.0,3661620.0,13219342.0,2640030.0,1021590.0,1072100.0,50510.0,1000000.0,21590.0,1021590.0,15289727.0,-3080238.0,-2379271.0,,50510.0,1072100.0,50510.0,1000000.0,1000000.0,2348572.0,-2348572.0,4656.0,,21590.0,30699.0,,267.0,,2216793.0,,1e-05,10000000.0,955057.0,949477.0,15783207.0,18000000.0,,,,100000.0,-2379271.0,,,493480.0,100000.0,1075000.0,,-13027115.0,,,,369884.0,,,,1.0,,,,,,486101.0,9.89,,,,,,,9557722.0,,,323607.0,,,15783207.0,369884.0,633940.0,,,3945153.0
2021-06-30,2021-08-10,10-Q,"Virpax Pharmaceuticals,Â Inc.",VRPX,CIK0001708331,USD,2779866.0,,291406.0,47748.0,22906214.0,,,11387696.0,11387696.0,,10466774.0,10466774.0,,,1e-05,100000000.0,4960153.0,4960153.0,50.0,,,,,,1073075.0,,-0.47,665560.0,0.06,1988972.0,-2343419.0,,,,34049.0,34049.0,,3851966.0,11387696.0,2830376.0,1021590.0,1072100.0,,1000000.0,21590.0,1021590.0,,,-2343419.0,,50510.0,1072100.0,50510.0,1000000.0,1000000.0,2305537.0,-2305537.0,64197.0,302993.0,21590.0,,-3833.0,5731.0,,,,1e-05,10000000.0,920922.0,703316.0,,,,,,,-2343419.0,,,,,316565.0,,-15370534.0,,,,,,,,,,,,,,736593.0,8.1,,,502197.0,,,,7535730.0,,,,,,,321427.0,448789.0,,,4958999.0
2021-09-30,2021-11-15,10-Q,"Virpax Pharmaceuticals,Â Inc.",VRPX,CIK0001708331,USD,1811809.0,,,9882.0,60047385.0,,,43273033.0,43273033.0,41713435.0,41713435.0,41713435.0,,,1e-05,100000000.0,11715182.0,11715182.0,117.0,,,,,,69898.0,,-0.53,600810.0,0.06,1551570.0,-3215744.0,,,,28892.0,28892.0,,1811809.0,43273033.0,1811809.0,,,,,,,,,-3215744.0,,,,,1100000.0,,3249774.0,-3249774.0,571.0,121585.0,,,62922.0,7666.0,,,,1e-05,10000000.0,1559598.0,421742.0,,,,,,,-3215744.0,,,,,1698204.0,,-18586278.0,,,,,,,,,415394.0,9.51,,,,669067.0,7.75,,,,,,,41461224.0,,,,,,,141773.0,211981.0,,,6011796.0
